Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
about
Multiple roles for nicotine in Parkinson's diseaseEmerging preclinical pharmacological targets for Parkinson's diseaseThe interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesiasRole for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian miceNicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitizationEvaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeysNicotine: specific role in angiogenesis, proliferation and apoptosis.Nicotine as a potential neuroprotective agent for Parkinson's disease.α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's diseaseNew treatments for the motor symptoms of Parkinson's disease.Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.Lynx1 supports neuronal health in the mouse dorsal striatum during aging: an ultrastructural investigation.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Associations between spontaneous movement abnormalities and psychotic-like experiences in the general population.Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function miceNicotine and Parkinson's disease: implications for therapy.Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian StriatumBDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.Nicotinic ACh receptors in the hippocampus: role in excitability and plasticity.α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesiasNicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal functionα4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseCharacterization of a nicotine-sensitive neuronal population in rat entorhinal cortex.Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.Targeting nicotinic receptors for Parkinson's disease therapy.
P2860
Q22252514-8F5D3FFB-D93D-4797-A1C5-DF1D270D4397Q26764724-D13E950F-DDD7-470C-B300-896F09839654Q26826951-59ACB5DA-8FB5-4300-A264-8589B02598ACQ30450052-FB4ED2E5-0E24-41BB-AA07-709A420EAA7DQ30475334-ADDBBBC7-16B1-49FF-895D-007FE66F2667Q33790163-414BE4CB-6E56-45A1-9557-DBE58BC14453Q33917311-6CCA8F0B-E152-4AAD-9567-AB5745507367Q34112026-A20B790A-BC93-4958-A79B-92CA8BAE6342Q34186299-986415A6-71FE-4B72-B36B-8CDF3B25FCCEQ34229828-9A834C3E-7937-4FD4-AB94-6EB3F8A613BEQ34281003-3E74E6B6-4BBF-4444-B6A3-BF1A5CE0EE85Q34309950-F334A6C9-A2DB-4E59-B2AF-30068790E07EQ34443682-A8FE2686-89F8-4B0E-ACA8-DDC8B9CBC914Q34770504-A3F25C14-C80C-45DC-8616-5EFC5F6BB29CQ34793270-D4A095DC-F538-4BC7-BD75-C35849965ACDQ35097046-2262CD0C-2A94-4589-AB4A-7D6B20993560Q35142884-846E7C6D-B4ED-462E-A29F-A83BCC723455Q35188119-B55DE9AA-48E7-462B-A060-4F3CFB2B9B6CQ35207319-EEE3A959-064C-4BD2-8F6E-4D63303CD8CFQ35264378-2B72B155-57AA-4710-89CE-E2C62121F7CFQ35376142-22F7A4A2-36D0-4AAB-9437-EF7B4FFD8267Q35533526-87CD982F-42D6-4342-B96E-F0A2FCB8DC6EQ35601652-9218B707-1CC7-408D-B537-CCAE828B1ACCQ35690133-BA82870F-8AAD-4096-9D62-8679B09E4506Q35690145-16689323-7846-4878-A861-6F854ED3E969Q35776860-94C39873-E238-4942-B393-688C3BA491F7Q36034592-DE7A6F38-E23E-42F3-B78F-66B651A6C255Q36177241-AEEE90D7-4EDC-426B-9055-1BE2277F83CAQ36349953-FA759C1C-6F49-43E5-B86F-3EB4D63B05D7Q36469995-466F0F3A-1857-4E16-B213-DFF3D8A1C9BAQ36880148-C488C53B-1E69-49C5-AC3C-145AB358A2A0Q36936920-77D3E4BC-B92F-4DAC-B1BC-4A9092FB74CEQ36936930-9356624F-DF6E-428B-9B27-45A4323317A1Q37193201-12E8E922-3076-4E80-8698-A19E6C92385DQ37209730-0FA3927A-301E-4E63-A033-A5F05A728777Q37396117-89933333-AA9C-40F4-A011-83461DB0FDB9Q37508589-A10113DF-459E-4651-A95A-F83184A5F312Q37603891-61F2E516-68E5-4F22-83D2-453C15630EF9Q37708588-9A3C9DB5-41D8-4EF4-B5BD-710096D3B7A6Q37916643-DD0F1DC8-2D47-4B22-BB74-89F0B8D9B515
P2860
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@en
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@nl
type
label
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@en
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@nl
prefLabel
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@en
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@nl
P2093
P356
P1433
P1476
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
@en
P2093
Donato Di Monte
Heather Cox
J William Langston
Kathryn O'Leary
Maryka Quik
Neeraja Parameswaran
P304
P356
10.1002/ANA.21203
P577
2007-12-01T00:00:00Z